EUA
Lilly SARS-CoV-2 Assay
FDA Emergency Use Authorization · Eli Lilly and Company · Sep 21, 2020
Key facts
| Product | Lilly SARS-CoV-2 Assay |
|---|---|
| Company | Eli Lilly and Company |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Sep 21, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: